PodParley PodParley

Season 1 / Ep. 11 (Dec 3, 2020) - Tech Impact and IT Works

Episode 11 of the United for Impact - Stories of Change, Progress, and the People Making it Happen podcast, hosted by Stand By Me Delaware, titled "Season 1 / Ep. 11 (Dec 3, 2020) - Tech Impact and IT Works" was published on December 3, 2020 and runs 19 minutes.

December 3, 2020 ·19m · United for Impact - Stories of Change, Progress, and the People Making it Happen

0:00 / 0:00

This episode focuses outside the immediate Stand By Me universe, and onto the Tech Impact / IT Works programs. Tech Impact is a nonprofit whose mission is to empower communities and nonprofits to use technology to better serve our world. The IT Works program prepares young adults for IT careers, without the need for a degree. Joining us on this episode are Tracey Mulveny, Carla Markell, and Orrin White to discuss Tech Impact and IT Works, how they benefit the Wilmington, DE community, ...

This episode focuses outside the immediate Stand By Me universe, and onto the Tech Impact / IT Works programs.  Tech Impact is a nonprofit whose mission is to empower communities and nonprofits to use technology to better serve our world. The IT Works program prepares young adults for IT careers, without the need for a degree.

Joining us on this episode are Tracey Mulveny, Carla Markell, and Orrin White to discuss Tech Impact and IT Works, how they benefit the Wilmington, DE community, how interested individuals can participate, and how the program mission aligns with Stand By Me's goals of financial empowerment for Delawareans.

Stand By Me® provides Delawareans with a Personal Financial Coach and a toolkit to navigate the challenges leading to personal financial security. The Delaware Financial Empowerment Partnership (DFEP) is a joint venture of the State of Delaware and the United Way of Delaware working together to combine resources and to create and implement an innovative package of financial empowerment services. We are joined by a coalition of non-profit organizations, corporations, foundations and educational institutions.

Support the show

Founder's Focus Gary Beach For more than 25 years, TECH CORPS has worked to ensure K through 12th grade students in the United States have equal access to technology programs, skills and resources that enhance early learning and prepare them for college or career.Founder’s Focus invites you along for the journey as we examine technology and how it impacts the way we work and live. Agenda 559 Podcast Agenda 559 Our mission is to unite, educate and inspire our communities, provide insight, opportunity and conversations that will impact the world in positive, constructive manner. Agenda 559 stands as an outlet for people and talents of the Central Valley to be heard and expressed. Together we can build a better tomorrow. Support this podcast: https://anchor.fm/thaddis-johnson-jr/support SCREAM with Ryan C. Showers SCREAM with Ryan C. Showers "SCREAM with Ryan C. Showers" is podcast show that explores the Scream film franchise in deep, focused analysis. It is the goal of this show to unite the engaging, film critic analysis with a fan's passion and love for the mythology of Scream. This podcast aims to give equal airtime to Scream (1996), Scream 2, Scream 3, Scream 4, Scream (2022), Scream 6, and the upcoming Scream 7, as well as Scream-adjacent topics. Episode coverage will include character development, storylines, themes, symbolism, filmmaking techniques and craftsmanship, the horror genre, cinematic legacies, comparative discussions, and cultural impacts. In addition, "SCREAM with Ryan C. Showers" will provide coverage and discourse of news about upcoming installments in the movie series. Exploring Best Practices for Diagnosis & Management of Adult-Onset Still's Disease AOSD Podcast Adult-onset Still’s disease (AOSD) is a rare, polygenic autoinflammatory syndrome with a pathogenesis similar to systemic juvenile inflammatory arthritis. Join Drs. Petros Efthimiou and Olga Petryna as they discuss making the diagnosis of AOSD through interpretation of clinical and laboratory findings and careful exclusion of other diseases. The faculty review the evidence related to the variety of medications often used to treat patients with AOSD, focusing on canakinumab, the only medication approved in the United States for the disease.
URL copied to clipboard!